Palisade Bio Inc (PALI)

Currency in USD
1.845
-0.055(-2.89%)
Real-time Data·
PALI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8201.930
52 wk Range
0.5302.640
Key Statistics
Prev. Close
1.9
Open
1.93
Day's Range
1.82-1.93
52 wk Range
0.53-2.64
Volume
830.59K
Average Volume (3m)
5.12M
1-Year Change
111.5583%
Book Value / Share
0.35
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PALI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.000
Upside
+550.41%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Palisade Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Palisade Bio Company Profile

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company’s lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn’s disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

Compare PALI to Peers and Sector

Metrics to compare
PALI
Peers
Sector
Relationship
P/E Ratio
−25.2x−2.2x−0.6x
PEG Ratio
−0.290.050.00
Price/Book
88.2x3.4x2.6x
Price / LTM Sales
-156.8x3.3x
Upside (Analyst Target)
294.7%63.5%44.5%
Fair Value Upside
Unlock−5.2%5.0%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.000
(+550.41% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy5.00+171.00%-New Coverage24/02/2026
B.Riley
Buy7.00+279.40%-New Coverage09/01/2026
Clear Street
Buy12.00+550.41%-New Coverage30/12/2025
Piper Sandler
Buy25.00+1,255.01%-New Coverage29/12/2025
Maxim Group
Buy2.00+8.40%8.00Maintain26/03/2025

Earnings

Latest Release
Nov 10, 2025
EPS / Forecast
-0.38 / -0.55
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

97.73
ITRI
+0.59%
1.680
CHRS
0.00%
0.136
QNCX
+3.26%
37.400
AXTI
-8.71%
4.000
BCOMF
0.00%

FAQ

What Is the Palisade Bio (PALI) Share Price Today?

The Palisade Bio stock price today is 1.845 USD.

What Stock Exchange Does Palisade Bio (PALI) Trade On?

Palisade Bio is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Palisade Bio?

The stock symbol (also called a 'ticker') for Palisade Bio is "PALI."

What Is the Current Palisade Bio Market Cap?

As of today, Palisade Bio market cap is 275.950M USD.

What Is Palisade Bio's (PALI) Earnings Per Share (TTM)?

The Palisade Bio EPS is currently -2.331 (Trailing Twelve Months).

Is PALI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Palisade Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Palisade Bio Stock Split?

Palisade Bio has split 5 times. (See the PALI stock split history page for full effective split date and price information.)

How Many Employees Does Palisade Bio Have?

Palisade Bio has 8 employees.

What is the current trading status of Palisade Bio (PALI)?

As of 26/02/2026, Palisade Bio (PALI) is trading at a price of 1.845 USD, with a previous close of 1.900 USD. The stock has fluctuated within a day range of 1.820 USD to 1.930 USD, while its 52-week range spans from 0.530 USD to 2.640 USD.

What Is Palisade Bio (PALI) Price Target According to Analysts?

The average 12-month price target for Palisade Bio is 12.000 USD, with a high estimate of 25 USD and a low estimate of 5 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +550.41% Upside potential.

What Is the PALI Premarket Price?

PALI's last pre-market stock price is 1.864 USD. The pre-market share volume is 23,360.000, and the stock has decreased by -0.036, or -1.890%.

What Is the PALI After Hours Price?

PALI's last after hours stock price is 1.920 USD, the stock has decreased by 0.020, or 1.050%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.